This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Mid-Caps With Upside: Analysts

7. Dendreon (DNDN) is a biotechnology company involved in discovering and developing immunology based therapeutic products to fight cancer.

The company reported loss of 64 cents per share for 2010 fourth quarter against 28 cents and 56 cents loss per share in the year-ago and quarter-ago periods, respectively. Loss per share for 2011 is pegged at $2.23, in comparison to loss of $3.18 per share for 2010. The company is anticipated to turn profitable in 2012 with earnings per share of 68 cents.

Of the 21 analysts covering the stock, 14 recommend buying, 5 suggest holding and 2 rate selling, representing 67% buy ratings. In comparison, MannKind (MNKD) and Agenus (AGEN) have buy ratings of 17% and 0%, respectively.

The stock has 61% upside over the next 12 months with a consensus target price of $52.7, according to analysts polled by Bloomberg.

4 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
LCC $0.00 0.00%
CLWR $0.00 0.00%
DNDN $0.06 -6.02%
NKTR $11.95 0.00%
TIVO $10.92 0.00%


DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs